Toggle light / dark theme

Get the latest international news and world events from around the world.

Log in for authorized contributors

Japan takes Fugaku supercomputer offlline after cyberattack

The Fugaku supercomputer operated by Japan’s RIKEN Center for Computational Science has been taken offline following a security breach.

The organization says that between November 10 and 13, an unauthorized party exploited the public dashboard displaying Fugaku’s operational status to gain access to multiple internal servers.

Although the research center has yet to determine the access method, RIKEN’s investigation confirmed that the intruder accessed some servers to plant malware that targeted user data.

Apple reports outages affecting iCloud Mail, AppleCare and more

Apple is reporting service disruptions affecting several of its services, including iCloud Mail, iCloud Account & Sign In, Apple School Manager, and Schoolwork.

According to Apple’s System Status page, at least six services were experiencing issues or outages as of 2:10 PM ET on November 17, 2026.

The most widespread issue affects iCloud Account & Sign In, which Apple lists as an ongoing issue affecting all users.

Tor releases emergency update amid ongoing DDoS attack

The Tor Project has released a security update for its network relay software to increase defenses against an ongoing distributed denial-of-service attack that it says has overwhelmed relays and affected most operators.

Tor version 0.4.9.17 includes a series of security fixes, including one the project described as especially important for relay denial-of-service defenses involving IPv6 handling.

“This release comes in rapid response to the ongoing DDoS attack on the network, which has affected most relay operators,” the Tor Project said in its release announcement.

Microsoft testing Remote Lock for lost or stolen Windows devices

Microsoft is testing a new feature that lets enterprise IT administrators remotely lock stolen or lost Windows devices without wiping them.

Named Remote Lock, this new feature is shipping to devices upgraded to Windows 11 Insider Preview builds in the Beta (Build 26320.10003) and Experimental (Build 26340.10013) channels.

Admins can use Microsoft Intune custom configuration profiles to lock Microsoft Entra-joined, hybrid-joined, or MDM-enrolled devices that run Windows Enterprise, Education, or Pro.

Blocking excess scarring helps prevent heart failure development

Most heart failure cases are caused to a large degree by a buildup of excess scar tissue in the heart, which currently has no treatments. Now, researchers have successfully prevented the development of severe heart failure in a mouse model of heart attack by blocking a protein that triggers the formation of excessive scar tissue.

Reducing the level of this protein, called AEBP1, after a heart attack or prolonged hypertension could be a promising therapy to prevent heart failure development.

“For the first time, we show that if we suppress AEBP1, it prevents heart failure progression and preserves cardiac function,” says Thirupura Shankar, Ph.D., a postdoctoral researcher in the Nora Eccles Harrison Cardiovascular Research Training Institute at University of Utah Health and first author on the study.

Stigmatizing patient details can push AI to deprioritize high-risk emergency cases

Artificial intelligence (AI)-driven tools used in emergency triage may be susceptible to the same clinical stigmas associated with human assessments, researchers at UT Southwestern Medical Center reported in a study published in npj Digital Medicine. Their findings suggest this could result in harmful biases and wrongful prioritization of patients.

“Wording matters. Because AI models process the words we use to describe patients, stigmatizing language can steer clinicians away from the patients who need care the most,” said first author Philip Jarrett, M.D., MBA, assistant professor of emergency medicine. “This study is part of a broader research program on how clinical information should be presented to AI so it can safely help prioritize emergency patients competing for limited resources.”

The team analyzed patient records from emergency departments (EDs) at two major academic institutions: Stanford Medicine in California and Beth Israel Deaconess Medical Center in Massachusetts. They paired patients with similar initial condition severity levels, then asked three open-source AI large language models (LLMs) to predict which patients were more likely to deteriorate and who should be prioritized for care. Before demographic, social or potentially stigmatizing information was added, all three models identified higher-risk patients at rates well above chance.

Tirzepatide moves more than half of treated teens below obesity threshold, new clinical trial reports

Tirzepatide (Zepbound) is a once-weekly injectable medication that hits two targets at once. This dual-action drug mimics the effects of two natural gut hormones in the body—glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1). Working together, these hormones keep blood sugar in check, slow the movement of food through the gut and signal the brain about fullness, which helps manage appetite and food intake.

A Phase III clinical trial called SURMOUNT-ADOLESCENTS tested whether a once-weekly dose of tirzepatide combined with healthy lifestyle counseling is safe and effective for helping teenagers lose weight and improve their health.

A total of 160 teenagers across 31 medical centers in six countries who had obesity or were overweight with at least one related health complication such as high blood pressure or prediabetes received either a once-weekly shot of tirzepatide or a placebo for 72 weeks.

Key immune driver of pancreatic cancer points to combination treatment for slowing progression

Researchers from The University of Texas MD Anderson Cancer Center have discovered that the IL-18 inflammatory protein helps pancreatic tumors grow and evade the immune system, highlighting its potential as a therapeutic target for pancreatic cancer.

Reducing levels of IL-18 in preclinical models reshaped the tumor microenvironment, slowed tumor growth, improved survival and enhanced the effects of KRAS-targeted therapies.

The study, published in Gastroenterology, was co-led by Yang Chen, Ph.D., assistant professor of Translational Molecular Pathology, and Xinlei Sun, Ph.D., postdoctoral fellow in Translational Molecular Pathology.

Human skin models reveal how herpes spreads unevenly among neighboring cells

Researchers at the Max Delbrück Center and University Medical Center Hamburg-Eppendorf have traced how herpes simplex virus 1 infection progresses among neighboring skin cells in skin organoids. The work is published in Science Advances.

Most people think of herpes simplex virus 1 (HSV-1) as a mere cosmetic problem: The virus can cause outbreaks of cold sores on the lips or face, which usually heal on their own within two weeks. But HSV-1 infection can be more sinister. The virus infects sensory nerve cells in the face, where it usually remains dormant.

In rare cases, it travels to the central nervous system and causes life-threatening brain inflammation. HSV-1 is also being investigated for potentially playing a role in Alzheimer’s disease—its lifelong persistence in our nervous system may eventually damage nerve cells.